The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions.If you have any queries about the SPCs on our website then please e-mail vetinfo@hpra.ie


CANIXIN Pi/L lyophilisate and suspension for suspension for injection for dogs

. Lyophilisate and suspension for suspension for injection

Virbac S.A.VPA10988/103/001

Main Information

Trade NameCANIXIN Pi/L lyophilisate and suspension for suspension for injection for dogs
Active SubstancesCanine Parainfluenza, live
Leptospira interrogans serogroup canicola, inactivated
Leptospira interrogans serogroup icterohaemorragiae, inactivated
Strength.
Dosage FormLyophilisate and suspension for suspension for injection
Licence HolderVirbac S.A.
Licence NumberVPA10988/103/001

Group Information

ATC CodeQI07AI08 live canine parainfluenza virus + inactivated leptospira
Therapeutic ClassImmunological
SpeciesDogs

Status

Authorised/WithdrawnAuthorised
Licence Issued13/04/2017
Legal StatusPOM: Prescription Only Medicine as defined in relevant national legislation

Documents

Summary of Product CharacteristicsPDF Version
Package LeafletNo document available
Public Assessment ReportNo document available
« Back